RxDoctor Payments Data

Stuart Bussell, MD

Colon & Rectal Surgery · Danbury, CTNPI 1881636447

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.0% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Medtronic at 53.1% of the total. Reporting peaked in 2024 at $257 and has fallen 85.0% since, to $39 in 2025. That places this record below the midpoint for colon & rectal surgery clinicians in CT, where the typical reported total is $1,507.

$689in general payments, 2019–2025

Across 27 payments — averaging $25.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$366
  • KCI USA, Inc.$73
  • W. L. Gore & Associates, Inc.$72
  • Kerecis Limited$39
  • E.r. Squibb & Sons, L.L.C.$35
  • AMAG Pharmaceuticals, Inc.$35
  • plus $70 from 4 others

What the payments were for

  • Food & beverage$65495%
  • Education$355%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$689 in reported general payments places this provider in the 35th percentile of 48 colon & rectal surgery providers in Connecticut.

See all colon & rectal surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$181,873
Medicare patients
336
Services billed
815

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates22$1,317
Colestipol Hcl19$1,056
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl38$591
Hydrocortisone17$229
Neomycin Sulfate40$212
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen31$172
Metronidazole47$117
Oxycodone Hcl12$48

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Danbury

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →